NEXPOINT ASSET MANAGEMENT, L.P. - PROGENICS PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 131 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
NEXPOINT ASSET MANAGEMENT, L.P. ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2020$1,714,000
-25.3%
450,9250.0%0.32%
+86.2%
Q4 2019$2,295,000
-36.7%
450,925
-37.1%
0.17%
-23.0%
Q3 2019$3,624,000–716,880–0.23%–
 Download
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q1 2020.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders